Journal article
Abstract P2-11-10: Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR+ breast cancer in the TEAM trial
Abstract
Abstract
Background: Women with HR+ breast cancer experience a persistent risk of distant recurrence (DR) even after completion of 5 years of adjuvant endocrine therapy, with more than 50% of DR occurring after 5 years (late DR). The prognostic genomic signatures currently being used in the clinic were not developed or optimized specifically for late DR. We have previously shown that the Breast Cancer Index (BCI) and BCIN+ …
Authors
Bartlett JM; Xu K; Wong J; Pond GR; Zhang Y; Spears M; Salunga R; Mallon E; Taylor KJ; Hasenburg A
Journal
Cancer Research, Vol. 83, No. 5_Supplement,
Publisher
American Association for Cancer Research (AACR)
Publication Date
March 1, 2023
DOI
10.1158/1538-7445.sabcs22-p2-11-10
ISSN
0008-5472